astemizole has been researched along with Autoimmune Diabetes in 1 studies
Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
astemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fourteen patients with type I (insulin-dependent) diabetes and mild nonproliferative diabetic retinopathy were treated with combined astemizole, 20 mg, and ranitidine, 600 mg, or an identical placebo for 6 months in a double-masked fashion." | 5.08 | Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study. ( D'Antonio, JA; Eller, AW; Friberg, TR; Gardner, TW; Hollis, TM, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gardner, TW | 1 |
| Eller, AW | 1 |
| Friberg, TR | 1 |
| D'Antonio, JA | 1 |
| Hollis, TM | 1 |
1 trial available for astemizole and Autoimmune Diabetes
| Article | Year |
|---|---|
Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
Topics: Adult; Astemizole; Blood-Retinal Barrier; Capillary Permeability; Diabetes Mellitus, Type 1; Diabeti | 1995 |